Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition
Abstract Hepatocellular carcinoma (HCC) is a malignancy with high morbidity and mortality but lacks effective treatments thus far.Although the emergence of immune checkpoint inhibitors in recent years has shed light Classic Cap Box on the treatment of HCC, a considerable number of patients are still unable to achieve durable and ideal clinical bene